美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BriaCell Therapeutics Corp. Warrant

0.0009

0.0000

成交量：- -

成交額：282.82

市值：1,579.59

市盈率：0.00

高：0.0009

開：0.0009

低：0.0009

收：0.0009

52周最高：0.2500

52周最低：0.0009

股本：175.51萬

流通股本：175.51萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-53.2836

淨資產收益率：-444.07%

總資產收益率：-161.64%

市淨率：0.00

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

BriaCell Therapeutics Corp. Warrant

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://briacell.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

BriaCell Therapeutics Corp.於2006年7月26日在不列顛哥倫比亞省成立。該公司是一家臨床階段的生物技術公司，正在開發新的免疫療法，以改變癌症治療。免疫療法在抗擊癌症的鬥爭中走在了前列，因為它們利用人體自身的免疫系統來識別並摧毀癌細胞。該公司目前正在推進其Bria-IMT靶向免疫療法與免疫檢查點抑製劑聯合用於晚期轉移性乳腺癌的關鍵1期3期研究。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BCTXW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCTXW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCTXW\",,,,,undefined,":{"symbol":"BCTXW","market":"US","secType":"STK","nameCN":"BriaCell Therapeutics Corp. Warrant","latestPrice":0.0009,"timestamp":1772139600000,"preClose":0.0009,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":1755102,"shares":1755102,"eps":-53.2836,"marketStatus":"停牌","change":0,"latestTime":"03-24 04:55:48 EDT","open":0.0009,"high":0.0009,"low":0.0009,"amount":282.819675,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-53.2836,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0009,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCTXW\",,,,,undefined,":{"symbol":"BCTXW","floatShares":1755102,"roa":"-161.64%","roe":"-444.07%","lyrEps":0,"shares":1755102,"dividePrice":0,"high":0.0009,"amplitude":0,"preClose":0.0009,"low":0.0009,"week52Low":0.0009,"pbRate":"0.00","week52High":0.25,"institutionHeld":0,"latestPrice":0.0009,"eps":-53.2836,"divideRate":0,"volume":0,"delay":0,"ttmEps":-53.2836,"open":0.0009,"prevYearClose":0.0528,"prevWeekClose":0.0028,"prevMonthClose":0.0099,"prevQuarterClose":0.0528},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCTXW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-27","symbol":"BCTXW","reason":null,"defaultRemindTime":1772202600000,"announcedDate":"2026-02-26","type":"delisting","dateTimestamp":1772168400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCTXW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCTXW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://briacell.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.6786},{"period":"3month","weight":-0.98},{"period":"6month","weight":-0.9677},{"period":"1year","weight":-0.9918},{"period":"ytd","weight":-0.983}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"BriaCell Therapeutics Corp.於2006年7月26日在不列顛哥倫比亞省成立。該公司是一家臨床階段的生物技術公司，正在開發新的免疫療法，以改變癌症治療。免疫療法在抗擊癌症的鬥爭中走在了前列，因為它們利用人體自身的免疫系統來識別並摧毀癌細胞。該公司目前正在推進其Bria-IMT靶向免疫療法與免疫檢查點抑製劑聯合用於晚期轉移性乳腺癌的關鍵1期3期研究。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.285155},{"month":2,"riseRate":0.6,"avgChangeRate":-0.205094},{"month":3,"riseRate":0.4,"avgChangeRate":0.124364},{"month":4,"riseRate":0.4,"avgChangeRate":-0.101785},{"month":5,"riseRate":0,"avgChangeRate":-0.266597},{"month":6,"riseRate":0.6,"avgChangeRate":0.102918},{"month":7,"riseRate":0.2,"avgChangeRate":-0.13671},{"month":8,"riseRate":0.8,"avgChangeRate":0.254238},{"month":9,"riseRate":0.6,"avgChangeRate":0.162156},{"month":10,"riseRate":0.2,"avgChangeRate":0.010978},{"month":11,"riseRate":0.6,"avgChangeRate":0.177117},{"month":12,"riseRate":0.6,"avgChangeRate":0.002481}],"exchange":"NASDAQ","name":"BriaCell Therapeutics Corp. Warrant","nameEN":"BriaCell Therapeutics Corp. Warrant"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BCTXW\",market:\"US\",,,undefined,":null}}